Earlier onset of atrial fibrillation (AF) is associated with increased risk of developing all-cause dementia, vascular dementia (VD), and Alzheimer disease (AD), according to a study published online Nov. 8 in JAMA Network Open.
Considerable shortages of minoxidil recorded in greater DC area
There are considerable shortages of oral minoxidil 2.5 mg and 10 mg tablets, used for treatment of androgenetic alopecia, within the District of Columbia, Maryland, and Northern Virginia (DMV) area, according to a research letter published online Oct. 26 in the Journal of Drugs in Dermatology.
Q&A: Treatment for a parastomal hernia
Question: My friend had a stoma created after years of managing Crohn’s disease. She recently had surgery to repair a hernia. What is a stoma, and are these types of hernias common? What is the typical treatment?
About 1 in 6 older Australians experiences elder abuse. Here are the reasons they don’t get help
Each year, many older Australians experience abuse, neglect or financial exploitation, usually at the hands of their adult children or other close relatives.
Babies are contracting salmonella after handling pet food, FDA warns
Two federal health agencies are investigating a salmonella outbreak linked to dog food that has sickened seven people in seven states, nearly all of them infants.
How much vision loss impairs your driving? New study has answers
A Mr. Magoo with thick glasses peering out from behind the wheel might not inspire confidence from his fellow motorists, but a new study shows other types of vision loss might be even more dangerous while driving.
Researchers reveal sex-dimorphic functions of intestinal MCT1 in regulating metabolic homeostasis
A team of researchers led by Prof. Chen Yan from Shanghai Institute of Nutrition and Health (SINH) of the Chinese Academy of Sciences has revealed, for the first time, that intestinal monocarboxylate transporter 1 (MCT1) can regulate glucose homeostasis and energy metabolism in a sex-dimorphic pattern. The study was published online in Life Metabolism.
ZAMMSA ordered to recall defective drugs from 42, 000 health centres
By Nation Reporter
THE Zambia Medicines and Medical Supplies Agency (ZAMMSA) has been ordered to recall defective drugs from the 42, 000 health kits imported from India through Mission Pharma.
And Speaker of the National Assembly Nelly Mutti yesterday stopped Health Minister Sylvia Masebo from attempting to mock her predecessor Dr Chitaly Chilufya who wanted to know if government had made a formal recall of defective drugs imported from India and were part of the drug kits in health centres.
Ms Masebo told Parliament yesterday that ZAMMSA had been directed to recall all the defective drugs from the 42, 000 health kits by its sister agency the Zambia Medicines Regulatory Authority (ZAMRA).
This was after Dr Chilufya asked Ms Masebo a question of clarification that defective drugs had nothing to do with an effective government but was part of science called pharmacovigilance and was therefore not new.
“It is part of medicine called pharmacovigilance. It is not new. It is not the new dawn administration that has introduced it. I want to support the minister of Health. What has happened cannot be criminalised. We will not politicise this issue. Has the Government done a formal recall of letromythene?” Dr Chilufya who is also PF Mansa Central MP asked.
But in response Ms Masebo quipped: “This is not about science. It is not a recall. The problem is that some people want to act smart.”
Speaker Nelly Mutti immediately chipped in and said Dr Chilufya had asked the question in good faith and there was nothing political about it.
The original question was from PF Bahati MP Leevan Chibombwe who wanted to know what Government would do with the drug procured from Mission Pharma of India because it had failed quality test as it was not dissolving when swallowed or even in a glass of water.
Ms Masebo then explained that Zambia Medicines and Medical Supplies Agency (ZAMMSA) had been directed to recall that drug from the 42,000 health kits by its sister agency the Zambia Medicines Regulatory Authority (ZAMRA).
She said it was not strange to procure defective medicines as such happened even from a good supplier such as Mission Pharma and so it will not stop dealing with them.
“Zambia has dealt with Mission Pharma for two decades but somewhere along the way, they fell off because PF failed to pay them their money but when we came in, we renegotiated. If the pharmacy is not keeping the drug well, it can lose its efficacy,” she said.
Ms Masebo said this in response to PF Chitambo MP Remember Mutale who wanted to know if the Government would continue to deal with Mission Pharma.
“Like any business, some suppliers do unethical things. But when you have a government which does not tolerate corruption, people are safe. The future is bright. Zambians are safer under HH and UPND government,” she said.
[/ihc-hide-content]
Where and how you sit matters when getting blood pressure taken at the doctor’s office
Millions of people with normal blood pressure may be misclassified as having blood pressure that is too high because of improper positioning when measurements are taken, new research suggests.
New tumor marker can detect gastric cancer with nearly 90% accuracy
A research team led by the Nagoya University Graduate School of Medicine has discovered that the stromal cell-derived factor 4 (SDF-4) protein is a reliable cancer marker. As simple blood tests accurately detect the protein, their findings suggest the potential of the marker in the early detection of gastric cancer.